Xtant Medical Holdings, Inc. / Insider Transactions

    Source Name Title Transaction Date Shares Price Value

    Configure table

    Control which columns are visible

    Export the current table view as a CSV file, which you can open in programs like Excel or Google Sheets.
    SEC Orbimed ROF II LLC N/A -73M $0.42 -$30.71M
    SEC Brandt Kevin D Chief Commercial Officer +42K $1.20 +$50.00K
    SEC Neils Scott C Chief Financial Officer -8.7K $0.61 -$5.29K
    SEC Browne Sean E President and CEO -131K $0.65 -$85.22K
    SEC Vizirgianakis Stavros G. N/A +2.3M $0.48 +$1.09M
    SEC Brandt Kevin D Chief Commercial Officer +387K $0.03 +$11.61K
    SEC Neils Scott C Chief Financial Officer +246K $0.01 +$2.46K
    SEC Browne Sean E President and CEO -160K $1.11 -$177.84K
    SEC Brandt Kevin D Chief Commercial Officer +155K $0.05 +$7.75K
    SEC Brandt Kevin D Chief Commercial Officer -8.8K $1.74 -$15.31K
    SEC Eggenberg Michael N/A +4.8M $0.01 +$48.00K
    SEC Orbimed ROF II LLC N/A +4.8M $0.01 +$48.00K
    SEC Rizzo Matthew N/A +4.8M $0.01 +$48.00K
    SEC Eggenberg Michael N/A +59M $1.07 +$62.87M
    SEC Orbimed ROF II LLC N/A +59M $1.07 +$62.87M
    SEC Rizzo Matthew N/A +59M $1.07 +$62.87M
    SEC Eggenberg Michael N/A +9M $7.20 +$64.64M
    SEC ORBIMED ADVISORS LLC N/A +9M $7.20 +$64.64M
    SEC Rizzo Matthew N/A +9M $7.20 +$64.64M
    SEC Goldberger Daniel S Chief Executive Officer +5K $2.34 +$11.70K
    SEC Swanson Kent L N/A +3.3K $2.83 +$9.34K
    SEC Kirschman David Louis EVP & Chief Scientific Officer +2K $2.99 +$5.98K
    SEC Swanson Kent L N/A +5K $3.00 +$15.00K
    SEC Kirschman David Louis EVP & Chief Scientific Officer +2K $2.90 +$5.80K
    SEC Goldberger Daniel S Chief Executive Officer +3K $2.80 +$8.40K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -5K $1.34 -$6.70K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $2.56 -$8.96K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $3.46 -$12.11K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $3.50 -$12.25K
    SEC Walsh Brian J VP-Sales & Marketing -6K $4.31 -$25.86K
    SEC Grainger Jeffry J VP-Corp Affairs & Gen. Counsel -3K $4.94 -$14.82K
    SEC Casciaro Gregory D President and CEO -2K $5.02 -$10.04K
    SEC Grainger Jeffry J VP-Corp Affairs & Gen. Counsel -2K $5.02 -$10.04K
    SEC Kahlenberg Timothy D Chief Financial Officer -1K $5.04 -$5.04K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $5.00 -$17.50K
    SEC Casciaro Gregory D President and CEO -2K $7.01 -$14.02K
    SEC Grainger Jeffry J VP-Corp Affairs & Gen. Counsel -5K $6.92 -$34.60K
    SEC Kahlenberg Timothy D Chief Financial Officer -1K $7.15 -$7.15K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $7.05 -$24.68K
    SEC Casciaro Gregory D President and CEO -2K $9.76 -$19.52K
    SEC Grainger Jeffry J VP-Corp Affairs & Gen. Counsel -5K $9.55 -$47.75K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $9.64 -$33.74K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $10.02 -$35.07K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $9.51 -$33.29K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -1.7K $10.00 -$17.00K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $9.11 -$31.88K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -7K $9.98 -$69.86K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $10.01 -$35.04K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $8.50 -$29.75K
    SEC Marco Philippe H VP-QA, Clinical & Reg. Affairs -3.5K $7.96 -$27.86K
    SEC Bellas Robert C JR N/A +25K $16.00 +$400.00K
    SEC FLAHERTY ROBERT E N/A +2K $16.00 +$32.00K

    Notifications